Bill
Therapeutic Goods (Charges) Amendment Bill 2017
passed, as at 2018-03-05. Health portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health
Recorded stages
- introduced — 2017-09-14
- second reading — 2017-09-14
- second reading — 2017-10-25
- other — 2017-10-25
- second reading — 2017-12-04
- second reading — 2017-12-04
- other — 2017-12-04
- third reading — 2017-12-04
- introduced — 2017-12-04
- second reading — 2017-12-04
- second reading — 2018-02-05
- second reading — 2018-02-15
- second reading — 2018-02-15
- committee — 2018-02-15
- third reading — 2018-02-15
- passed — 2018-02-15
- royal assent — 2018-03-05
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2017-09-14.
This bill would let the government set an annual fee for Australian companies that check whether medical devices are safe and well made.
It does this by allowing regulations to prescribe a charge for a conformity assessment body determination, which the Secretary can issue under the Therapeutic Goods Act.
The bill also makes minor changes to keep charging rules consistent when a determination is suspended and to apply annual charges to provisionally registered medicines listed under state laws.
- Enables regulations to set an annual charge for conformity assessment body determinations.
- Ensures the obligation to pay the annual charge continues during a suspension of the determination.
- Extends annual charges to provisionally registered goods entered in the Register by Commonwealth officers under a corresponding state law.
Australian corporations that hold a conformity assessment body determination and sponsors of provisionally registered medicines.
Sources
em
em supp
billhome
frl act